Front Row Advisors LLC
- SEC CIK
- 0001729254
- Latest filing
- Aug 13, 2026
TVRD holding history
Tvardi Therapeutics, Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVRD overviewAll 13F holders of TVRDFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $2
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $2 | <0.1% | +1 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q4 2025 | 1 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1 | $39 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1 | $23 | <0.1% | −1−50.0% | ReducedConverted for a 1-for-3 split | Holders |
| Q1 2025 | 6 | $30 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 6 | $37 | <0.1% | −1−10.0% | ReducedConverted for a 1-for-12 split | Holders |
| Q3 2024 | 80 | $25 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 80 | $21 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 80 | $73 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 80 | $59 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 80 | $134 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 80 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 80 | $0 | 0.0% | +80 | New | Holders |